Vivesto Signs Deal With Kazia Therapeutics To Acquire Full Cantrixil Rights
Reuters
03-31
March 31 (Reuters) - Vivesto AB :: *VIVESTO SIGNS DEAL WITH KAZIA THERAPEUTICS TO ACQUIRE FULL CANTRIXIL RIGHTS *TO ACQUIRE FULL RIGHTS, INCLUDING ALL INTELLECTUAL PROPERTY AND TRADEMARKS RIGHTS FOR DRUG CANDIDATE CANTRIXIL FOR 1 MUSD